Superworth

Prestige Consumer Healthcare EV/EBIT PBH

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2012.

Today, Oct 23, 2026
14.5×
10-year median
12.9×
Against its 10-year history
78th
percentile: 0 is its lowest day, 100 its highest
10-year range
9.7× to 24.1×
Peer median
9.5×

Prestige Consumer Healthcare's EV/EBIT is 14.5× as of Oct 23, 2026.

That is above its ten-year median of 12.9×, higher than on 78% of days in the last ten years.

Over that time it ranged from 9.7× in Mar 2019 to 24.1× in Jun 2017.

The median for 10 large drugmakers of a similar size is 9.5×.

EV/EBIT over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far14.5×10.2×15.6×
202511.7×11.2×16.2×
202415.0×11.8×16.0×
202312.2×11.7×14.2×
202213.6×12.1×14.6×
202114.6×11.1×15.0×
202010.8×10.5×13.6×
201911.5×9.7×11.5×
201811.3×11.2×16.1×
201715.9×15.2×24.1×
201619.9×15.3×20.3×
201516.6×15.6×20.6×
201420.1×11.7×20.1×
201314.1×12.6×15.3×
201214.4×14.4×19.4×

Against its peers

Companies in Drug Manufacturers - General nearest Prestige Consumer Healthcare's size, closest first, today.

CompanyEV/EBIT
PBHPrestige Consumer Healthcare14.5×
HRMYHarmony Biosciences6.9×
NRIXNurix Therapeutics7.1×
ANIPANI Pharmaceuticals10.5×
PAHCPhibro Animal Health11.7×
ANABAnaptysbion/m
PCRXPacira BioSciences7.6×
OGNOrganon9.5×
LQDALiquidia21.7×
ARQTArcutis Biotherapeutics111×
INDVIndivior Pharmaceuticals7.8×
Peer median9.5×

Where Prestige Consumer Healthcare ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Prestige Consumer Healthcare

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.